Palvella Therapeutics Publishes Systematic Review of Statin Use in Porokeratosis, Highlighting Need for FDA-Approved Therapies.

Palvella Therapeutics has announced a scientific publication in Clinical and Experimental Dermatology highlighting a systematic review of real-world statin evidence in porokeratosis. The review of 24 studies found that off-label cutaneous application of statins may be beneficial in treating the condition, which lacks FDA-approved therapies. The study underscores the need for development of a standardized, FDA-approved statin therapy.